A prominent no-show
Executive Summary
No one from GlaxoSmithKline attended the PhRMA annual meeting. GSK's board representative, Robert Ingram, participated in the March 27 board meeting via teleconference. GSK explained that "logistics" prevented anyone from attending in person. Ingram retired from day-to-day operations at GSK in December, but he is continuing to represent the company within PhRMA while working part time as vice chairman-pharmaceuticals (1"The Pink Sheet" Oct. 21, 2002, p. 27)...